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A nest in renal fibrosis?
J-L Bascands1, 2, J Klein1, 2 and JP Schanstra1, 2
Sakairi and collaborators show that some tubular cells as well as some 
interstitial myofibroblasts express the intermediate filament protein 
nestin. These findings evoke questions about the origin and role of these 
nestin-positive cells in the development of tubulointerstitial fibrosis.
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Renal tubulointerstitial fi brosis is, regard-
less of the initial insult, a histological hall-
mark of most forms of chronic kidney 
disease, and its presence has been strongly 
correlated to the progressive loss of renal 
function. Th e development of tubulointer-
stitial fi brosis in chronic kidney disease 
has therefore been associated with a poor 
long-term prognosis.1 Even though the 
currently used therapeutic approaches 
slow down the progression of tubulointer-
stitial fi brosis, they do not specifi cally tar-
get tubulointerstitial fi brosis. A number 
of groups have recently focused their 
research toward better understanding 
of the development of tubulointerstitial 
fi brosis, which is steadily increasing our 
knowledge of this important event in the 
progression of chronic kidney disease.
Sakairi and collaborators2 (this issue) 
identify the intermediate fi lament protein 
nestin as a new marker of the progression 
of tubulointerstitial fi brosis. Nestin was 
originally discovered in rat neuroepithe-
lial stem cells3 and, in further studies, was 
found to be expressed in rat, mouse, and 
human embryonic and fetal tissues. It was 
therefore initially thought that nestin was 
a typical marker of multilineage progeni-
tors, but more recent studies showed that 
nestin is also expressed in adult tissues, 
mainly in areas of regeneration.4 In addi-
tion, nestin was also shown to be induced 
in a variety of injured tissues, including the 
central nervous system, the liver, skeletal 
muscle, the pancreas, and odontoblasts.4 
In kidney development, nestin-positive 
progenitor cells have been detected in the 
mouse metanephric embryonic kidney,5 
and in the adult kidney nestin is selectively 
expressed in diff erentiated podocytes (Fig-
ure 1). As part of the cytoskeleton, nestin 
is probably involved in the stabilization of 
podocyte architecture.5 More recently, it 
has been shown that nestin is upregulated 
in podocytes in an experimental rat model 
of podocyte injury.6
Now Sakairi et al.2 present evidence of 
induction of nestin in an adult rat model 
of unilateral ureteral obstruction (UUO)-
induced tubulointerstitial fi brosis. Nota-
bly, even though a complete obstruction 
of the ureter is rarely found in humans, 
the widely used UUO animal model has 
the advantage that it mimics, in an accel-
erated manner, the diff erent stages lead-
ing to tubulointerstitial fi brosis: tubular 
atrophy, monocyte/macrophage infil-
trate, tubular proliferation, apoptosis, 
epithelial-to-mesenchymal transition, 
and extracellular matrix accumulation.7 
In UUO-induced tubulointerstitial fi bro-
sis, nestin expression was induced in both 
renal tubular cells and interstitial myofi -
broblasts. Th ese nestin-positive tubular 
and interstitial cells mainly appeared in 
areas with severe tubular damage. Th is 
location is consistent with areas where a 
process called epithelial-to-mesenchymal 
transition (EMT), which produces myofi -
broblasts, is described as occurring.8
Although myofi broblasts are thought 
to be the main cell type responsible for 
the production of tubulointerstitial fi bro-
sis,8 their origins and activation are still 
a matter of debate. Current knowledge 
allows us to presume that interstitial 
myofibroblasts can have three origins: 
(1) local activation of resident fi broblasts, 
(2) infi ltration from the circulation, and 
(3) EMT, a process that has been shown, 
in many animal models, to occur in an 
advanced stage of the development of 
tubulointerstitial fibrosis.9 The most 
oft en used marker to show the presence of 
myofi broblasts is α-smooth muscle actin 
(α-SMA). It has also been shown that this 
cell is positive for other cytoskeletal pro-
teins such as vimentin or desmin.8
Sakairi et al.2 show that all nestin-posi-
tive cells that accumulated in the intersti-
tium, 7 days aft er UUO, co-stained with 
α-SMA. Nestin- and α-SMA-positive cells 
continued to accumulate until day 13, the 
end point of the study. Together with the 
spindle-shaped morphological appear-
ance of these cells, the data strongly sug-
gest that these nestin-positive interstitial 
cells were myofi broblasts. Interestingly, 
not all α-SMA-positive interstitial cells 
stained positively for nestin, which sug-
gests that nestin might be a marker of 
tubulointerstitial injury distinct from 
conventional markers such as vimentin, 
HSP47, and α-SMA. Th is indicates the 
existence of two populations of intersti-
tial myofi broblasts: nestin positive and 
nestin negative. So why do some of these 
myofi broblasts express nestin? Does this 
mean that these cells are of a different 
origin than those that do not express nes-
tin, and/or have a diff erent function? It is 
possible that during chronic injury both 
nestin-positive and nestin-negative cells 
contribute to the development of intersti-
tial fi brosis whereas in situations in which 
the injury is removed these cells respond 
diff erently. For example, because nestin 
is also a marker of progenitor cells, one 
can speculate that nestin-positive cells are 
more easily engaged in a possible rever-
sion process. Further studies are necessary 
to elucidate this point.
Tubular nestin expression is concomi-
tant with interstitial nestin expression. 
Furthermore, all nestin-positive tubular 
cells co-stained with the mesenchymal 
marker vimentin, whereas none stained 
positively for E-cadherin; this suggests that 
these ‘tubular’ cells are closer to the mes-
enchymal than the epithelial phenotype. 
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Th ese data are consistent with previous 
work on other tissues showing an upregu-
lation of nestin when loss of intercellular 
contacts occurs.4 However, not all vimen-
tin-positive cells express nestin, which 
raises the same question as with nestin-
positive and -negative myofi broblasts: do 
they diff er in origin and/or function? For 
example, diff erence in nestin expression in 
tubular cells might change their destiny to 
death by apoptosis, as it has been shown, 
in vitro, that these transformed cells might 
be more susceptible than normal epithe-
lial cells to apoptosis.8
The molecular mechanism of nestin 
upregulation during injury is not well 
understood.4 Sakairi et al.2 show (1) that 
hypoxic tubules during UUO express 
nestin, and (2) that, in vitro, hypoxia 
induces nestin expression in renal epithe-
lial cells. However, it seems that hypoxia 
is not directly inducing nestin expres-
sion, but that nestin is induced second-
ary to the phenotypic changes induced 
by hypoxia. Sakairi et al.2 also show that 
the well-known profi brotic transforming 
growth factor-β also stimulated in vitro 
nestin expression. Transforming growth 
factor-β-induced expression of nestin 
was observed together with increased 
α-SMA expression in cultured fibrob-
lasts. Th us two events, important in the 
genesis of renal tubulointerstitial fi brosis, 
induce nestin: hypoxia and transform-
ing growth factor-β expression. The 
detailed molecular mechanism of nestin 
induction seems more complex, though. 
Whereas nestin protein levels were found 
to be overexpressed in the obstructed 
kidney, no increase in nestin mRNA was 
observed. Data from the study by Sakairi 
et al.2 argue for a decrease in proteasome 
activity concomitant with increased nes-
tin protein expression that can explain 
this discrepancy. Finally, in contrast to 
what is found in malignant tumors, where 
upregulation of nestin is highly correlated 
with the elevated proliferation and migra-
tory activity of malignant cells,4 Sakairi 
et al.2 mention that the nestin-positive 
cells in the obstructed kidney were not 
in a proliferating state, which suggests 
that nestin is expressed once the cell is 
in a more static state. Independently of 
the necessity to determine the precise 
molecular mechanism of nestin induction 
in tubulointerstitial fi brosis, it is impor-
tant to note that, because advanced tubu-
lointerstitial fi brosis leads to progressive 
hypoxia of renal tubules due to the accu-
mulation of extracellular matrix, and thus 
to enlargement of the tubulointerstitial 
space, the upregulation of nestin in such 
fi brotic areas links nestin expression to 
advanced stages of the fi brotic process.
In conclusion, Sakairi et al.2 identify 
the intermediate fi lament protein nestin 
as a new marker of myofi broblasts and 
dedifferentiated tubular cells in renal 
tubulointerstitial fi brosis. Th e concomi-
tant expression of nestin in both dediff er-
entiated tubular cells and myofi broblasts 
makes it tempting to speculate that nes-
tin-positive myofi broblasts accumulate by 
EMT. However, this remains to be con-
fi rmed before nestin can be considered 
a new temporal and possibly functional 
marker for EMT in the pathological con-
text of renal tubulointerstitial injury. Th e 
paper by Sakairi et al.2 brings to mind the 
old, but nonetheless recurrent, questions 
of the reversion of renal fi brosis and the 
existence of a ‘point of no return’10 in 
progressive renal disease. Indeed, as nes-
tin expression has been associated with 
multilineage progenitor cells,4 which 
suggests potential regenerative abilities 
of this type of nestin-positive cell, nes-
tin-positive mesenchymal cells might be 
possible targets for reversion of interstitial 
fi brosis once the (chronic) injury has been 
removed. In this context it would be inter-
esting to verify if there is a diff erence in 
the ability of nestin-positive and -negative 
myofi broblasts to undergo mesenchymal-
to-epithelial transition. On the other hand, 
as nestin is involved in the maintenance 
of the cytoskeletal structure and therefore 
could participate in the stabilization of the 
myofi broblasts’ structure, nestin expres-
sion could be a sign of an engagement 
in the scarring process, which has oft en 
been suggested as the point of no return 
in chronic renal disease.
Further studies will thus be neces-
sary to determine whether nestin is a 
marker of the establishment of a ‘cozy 
nest’ in which renal interstitial fi brosis 
progresses, or whether nestin, on the 
contrary, is a marker of cells that still 
have the potential to revert to their 
maternal phenotype.
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Figure 1 | Renal nestin expression under normal and pathological conditions. During 
embryogenesis, nestin progenitor cells are expressed in the metanephric mesenchyme mainly 
in the vascular cleft of the S-shaped body and in the vascular tuft of immature glomeruli of the 
capillary loop stage. In the newborn, transient nestin expression is localized in proximal tubular 
cells. In the adult kidney, nestin is expressed only in glomeruli — more precisely, in glomerular 
podocytes. Under pathological conditions, depending on the injury type, renal nestin upregulation 
can be observed in podocytes, and de novo nestin expression was observed in some tubular cells 
and myofibroblasts in areas with severe tubular damage and interstitial fibrosis.2,6 Question marks 
indicate that the origin of the nestin-positive myofibroblasts remains to be clearly established. EMT, 
epithelial-to-mesenchymal transition.
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